Hutchison China Meditech

(HNCMF)

Symbol has changed to a new ticker symbol

(HCM:LN)

By |

Profile

Hutchison China Meditech Ltd is an innovative biopharmaceutical company. The company is engaged in the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the Innovation Platform and Commercial Platform. The company has a portfolio of eight cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China.

Contact Information

Website: www.chi-med.com
Email: ir@chi-med.com
Main Phone: +852 21218200
Address: 2 Queen's Road Central
Address 2: 48th Floor, Cheung Kong Center
City / Town: Hong Kong
Country: HKG

Issuer Information

Exchange: GREY
CEO: Christian Hogg
Employees: 853
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Hutchison China Meditech Ltd is an innovative biopharmaceutical company. The company is engaged in the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the Innovation Platform and Commercial Platform. The company has a portfolio of eight cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China.

Contact Information

Website: www.chi-med.com
Email: ir@chi-med.com
Main Phone: +852 21218200
Address: 2 Queen's Road Central
Address 2: 48th Floor, Cheung Kong Center
City / Town: Hong Kong
Country: HKG

Issuer Information

Exchange: GREY
CEO: Christian Hogg
Employees: 853
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 5.11 $ 0. (0.00%)
Last Price 5.11 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 5.11
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 3.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 709,274,765.00 EPS (TTM) -0.11 PE Ratio N/A Exchange Greys